FI970258A0 - Nytt förfarande för framställning av biologiskt aktivt protein - Google Patents
Nytt förfarande för framställning av biologiskt aktivt proteinInfo
- Publication number
- FI970258A0 FI970258A0 FI970258A FI970258A FI970258A0 FI 970258 A0 FI970258 A0 FI 970258A0 FI 970258 A FI970258 A FI 970258A FI 970258 A FI970258 A FI 970258A FI 970258 A0 FI970258 A0 FI 970258A0
- Authority
- FI
- Finland
- Prior art keywords
- biologically active
- new method
- active protein
- producing biologically
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94810439 | 1994-07-25 | ||
EP94810439 | 1994-07-25 | ||
EP9502719 | 1995-07-12 | ||
PCT/EP1995/002719 WO1996003433A1 (en) | 1994-07-25 | 1995-07-12 | New process for the production of biologically active protein |
Publications (3)
Publication Number | Publication Date |
---|---|
FI970258A0 true FI970258A0 (sv) | 1997-01-22 |
FI970258A FI970258A (sv) | 1997-01-22 |
FI118385B FI118385B (sv) | 2007-10-31 |
Family
ID=8218293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970258A FI118385B (sv) | 1994-07-25 | 1997-01-22 | Nytt förfarande för framställning av biologiskt aktivt protein |
Country Status (19)
Country | Link |
---|---|
US (1) | US7057016B2 (sv) |
EP (1) | EP0779896B1 (sv) |
JP (2) | JPH11505404A (sv) |
KR (1) | KR100394532B1 (sv) |
AT (1) | ATE207934T1 (sv) |
AU (1) | AU699879B2 (sv) |
CA (1) | CA2194578A1 (sv) |
DE (1) | DE69523611T2 (sv) |
DK (1) | DK0779896T3 (sv) |
ES (1) | ES2166402T3 (sv) |
FI (1) | FI118385B (sv) |
HU (1) | HU222829B1 (sv) |
IL (1) | IL114702A (sv) |
NO (1) | NO317730B1 (sv) |
NZ (1) | NZ290374A (sv) |
PT (1) | PT779896E (sv) |
TW (1) | TW517059B (sv) |
WO (1) | WO1996003433A1 (sv) |
ZA (1) | ZA956139B (sv) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4019432B2 (ja) * | 1995-12-21 | 2007-12-12 | 味の素株式会社 | ヒトアクチビンaのリフォールディング方法 |
DE10026713A1 (de) * | 2000-05-30 | 2001-12-06 | Walter Sebald | Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta |
US20030134292A1 (en) * | 2001-10-30 | 2003-07-17 | Farchaus Joseph W. | Thermostable DNA polymerases and methods of making same |
FR2871061B1 (fr) * | 2004-06-04 | 2007-08-10 | Coletica Sa | Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif |
US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
US7955418B2 (en) | 2005-09-12 | 2011-06-07 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds or odors associated with same |
GB0604966D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Medicaments and proteins |
US8986769B2 (en) * | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
KR20120093993A (ko) | 2009-10-30 | 2012-08-23 | 아벨라 파마슈티칼스, 인코포레이티드 | 퇴행성 관절염 치료를 위한 디메틸설폭사이드 및 메틸설포닐메탄 제제 |
US10647777B2 (en) * | 2014-05-28 | 2020-05-12 | Genzyme Corporation | Methods of controlling the formation of disulfide bonds in protein solutions |
JP2016183118A (ja) * | 2015-03-25 | 2016-10-20 | 東ソー株式会社 | 増殖因子前駆体のリフォールディング方法 |
NZ754942A (en) | 2016-12-30 | 2023-02-24 | Biogend Therapeutics Co Ltd | Recombinant polypeptides, compositions, and methods thereof |
TW202330579A (zh) * | 2021-10-11 | 2023-08-01 | 高等教育聯邦系統 匹茲堡大學 | 經工程改造TGF-β單體及使用方法 |
GB2616476A (en) * | 2022-03-11 | 2023-09-13 | Multus Biotechnology Ltd | Recombinant transforming growth factor beta 3 in yeast |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0051985B2 (en) * | 1980-11-07 | 1989-12-27 | International Institute Of Cellular And Molecular Pathology (Icp) | Immunoassay of proteins |
GR79124B (sv) | 1982-12-22 | 1984-10-02 | Genentech Inc | |
US4620948A (en) | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
DE3587022T2 (de) | 1984-02-17 | 1993-06-17 | Genentech Inc | Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren. |
US4572798A (en) | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
US4731440A (en) | 1985-02-22 | 1988-03-15 | Monsanto Company | Method of somatotropin solubilization using dimethylsulfone and naturation |
IL78197A (en) | 1985-03-22 | 1991-07-18 | Genentech Inc | Nucleic acid encoding tgf-beta and its uses |
GB8508340D0 (en) | 1985-03-29 | 1985-05-09 | Creighton T E | Production of protein |
EP0208539A3 (en) | 1985-07-11 | 1988-08-03 | Repligen Corporation | Folding disulfide-cross-linkable proteins |
US5453363A (en) | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
JPH0759598B2 (ja) * | 1986-02-14 | 1995-06-28 | 藤沢薬品工業株式会社 | ヒトインスリン様成長因子▲i▼の製造法 |
NZ222168A (en) | 1986-10-20 | 1991-05-28 | Oncogene Science Inc | Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions |
AU612617B2 (en) | 1986-11-17 | 1991-07-18 | Sandoz Ag | Production and use of a novel t-cell suppressor factor |
FI100106B (sv) | 1986-12-05 | 1997-09-30 | Novartis Ag | Förfarande för framställning av en enkelsträngad hybridplasminogenakti vator |
US4931548A (en) | 1987-01-30 | 1990-06-05 | Techne Corporation | Heterodimer form of transforming growth factor-beta |
IL86090A (en) | 1987-04-16 | 1993-03-15 | Cetus Oncology Corp | Production of purified, biologically active, bacterially produced recombinant human csf-1 |
DE3855986T2 (de) | 1987-05-11 | 1998-02-05 | Chiron Corp | Prozess zur gewinnung von gereinigtem, oxidiertem, renaturiertem, rekombinantem interleukin-2 aus mikroorganismen |
US5162507A (en) | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
EP0293785A3 (en) * | 1987-05-29 | 1990-05-02 | Oncogen Limited Partnership | Cloning and expression of simian transforming growth factor-ss1 |
US4985544A (en) | 1987-08-04 | 1991-01-15 | Kyowa Hakko Kogyo Co., Ltd. | Process for renaturing fish growth hormone |
US5061786A (en) * | 1989-05-25 | 1991-10-29 | Genentech, Inc. | Biologically active polypeptides based on transforming growth factor-β |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
US5144006A (en) * | 1991-06-13 | 1992-09-01 | The Rockefeller University | Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides |
AU2738392A (en) * | 1991-11-11 | 1993-05-13 | Ciba-Geigy Ag | Novel hybrid transforming growth factors |
US5407810A (en) * | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
TW440566B (en) * | 1994-07-25 | 2001-06-16 | Novartis Ag | Novel process for the production of biologically active dimeric protein |
-
1995
- 1995-07-11 TW TW084107189A patent/TW517059B/zh not_active IP Right Cessation
- 1995-07-12 NZ NZ290374A patent/NZ290374A/en not_active IP Right Cessation
- 1995-07-12 DE DE69523611T patent/DE69523611T2/de not_active Expired - Lifetime
- 1995-07-12 ES ES95926858T patent/ES2166402T3/es not_active Expired - Lifetime
- 1995-07-12 PT PT95926858T patent/PT779896E/pt unknown
- 1995-07-12 HU HU9700211A patent/HU222829B1/hu not_active IP Right Cessation
- 1995-07-12 EP EP95926858A patent/EP0779896B1/en not_active Expired - Lifetime
- 1995-07-12 AT AT95926858T patent/ATE207934T1/de not_active IP Right Cessation
- 1995-07-12 CA CA002194578A patent/CA2194578A1/en not_active Abandoned
- 1995-07-12 WO PCT/EP1995/002719 patent/WO1996003433A1/en active IP Right Grant
- 1995-07-12 DK DK95926858T patent/DK0779896T3/da active
- 1995-07-12 JP JP8505401A patent/JPH11505404A/ja not_active Withdrawn
- 1995-07-12 KR KR1019970700477A patent/KR100394532B1/ko not_active IP Right Cessation
- 1995-07-12 AU AU31096/95A patent/AU699879B2/en not_active Ceased
- 1995-07-24 ZA ZA956139A patent/ZA956139B/xx unknown
- 1995-07-24 IL IL11470295A patent/IL114702A/xx not_active IP Right Cessation
-
1997
- 1997-01-22 FI FI970258A patent/FI118385B/sv active IP Right Grant
- 1997-01-24 NO NO19970326A patent/NO317730B1/no not_active IP Right Cessation
-
2001
- 2001-03-20 US US09/813,271 patent/US7057016B2/en not_active Expired - Fee Related
-
2006
- 2006-11-09 JP JP2006304238A patent/JP4354980B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69523611D1 (de) | 2001-12-06 |
US20020115834A1 (en) | 2002-08-22 |
DE69523611T2 (de) | 2002-06-20 |
NO970326L (no) | 1997-01-24 |
ES2166402T3 (es) | 2002-04-16 |
JP4354980B2 (ja) | 2009-10-28 |
IL114702A0 (en) | 1995-11-27 |
NZ290374A (en) | 1998-07-28 |
IL114702A (en) | 2005-03-20 |
CA2194578A1 (en) | 1996-02-08 |
NO970326D0 (no) | 1997-01-24 |
US7057016B2 (en) | 2006-06-06 |
HU222829B1 (hu) | 2003-11-28 |
PT779896E (pt) | 2002-03-28 |
EP0779896B1 (en) | 2001-10-31 |
FI118385B (sv) | 2007-10-31 |
DK0779896T3 (da) | 2002-02-18 |
EP0779896A1 (en) | 1997-06-25 |
AU3109695A (en) | 1996-02-22 |
TW517059B (en) | 2003-01-11 |
FI970258A (sv) | 1997-01-22 |
NO317730B1 (no) | 2004-12-13 |
HUT76667A (en) | 1997-10-28 |
JPH11505404A (ja) | 1999-05-21 |
AU699879B2 (en) | 1998-12-17 |
ZA956139B (en) | 1996-03-07 |
KR100394532B1 (ko) | 2003-10-22 |
JP2007082554A (ja) | 2007-04-05 |
ATE207934T1 (de) | 2001-11-15 |
WO1996003433A1 (en) | 1996-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970258A (sv) | Nytt förfarande för framställning av biologiskt aktivt protein | |
NO970325L (no) | Fremgangsmåte for fremstilling av biologisk aktivt dimerisk protein | |
ATE218579T1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
SE8303211L (sv) | Rena teichomycin a?712 singelfaktorer 1,2,3,4 och 5 och sett for deras framstellning | |
IT8421436A1 (it) | Un plasmide ricombinante, un microorganismo trasformante, un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina così prodotta | |
FI97299C (sv) | Förfarande för framställning av en kimerisk transformerande beta-växtfaktor | |
DE69023648D1 (de) | Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung. | |
SE9501285L (sv) | Förfarande för framställning av biologiskt aktiva proteiner | |
MX9700657A (es) | Nuevo proceso para la produccion de proteina biologicamente activa. | |
ATE185349T1 (de) | Verfahren zur herstellung von dolastatin 15 und deren zwischenprodukten | |
MX9700656A (es) | Proceso novedoso para la produccion de proteina dimerica biologicamente activa. | |
PL355852A1 (en) | Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients | |
ES2049021T3 (es) | Metodo de recuperar la proteina epi purificada a partir de una solucion, especialmente una solucion de fermentacion. | |
WO1997041207A3 (en) | Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector | |
DE3783425D1 (de) | Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen. | |
ES2004734A6 (es) | Procedimiento de obtencion de conjugados biologicamente activos de metaloproteina-albumina o metaloproteina-albumina-anticuerpos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |
|
FG | Patent granted |
Ref document number: 118385 Country of ref document: FI |